Zhenhao Qi

发表

IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines

Fei Huang, Dharmesh M. Patel, Han Chang, 2014, Molecular Cancer Therapeutics.

Mutations in the Hedgehog Pathway Genes SMO and PTCH1 in Human Gastric Tumors

Han Chang, H. Inzunza, J. Cogswell, 2013, PloS one.

Genome‐wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology

R. Petersen, A. Saykin, Sungeun Kim, 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Efficacy and safety of patritumab deruxtecan (HER3-DXd) in advanced/metastatic non-small cell lung cancer (NSCLC) without EGFR-activating mutations.

E. Smit, Melissa L. Johnson, E. Felip, 2022, Journal of Clinical Oncology.

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer

Melissa L. Johnson, P. Janne, Dong-Wan Kim, 2021, Cancer discovery.

Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC).

P. Jänne, Melissa L. Johnson, Dong-Wan Kim, 2021 .

Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin-Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform.

J. Cogswell, Lisu Wang, P. Vitazka, 2019, The Journal of molecular diagnostics : JMD.

A phase I study of AL101, a pan-NOTCH inhibitor, in patients (pts) with locally advanced or metastatic solid tumors.

J. Desai, S. Ramalingam, P. LoRusso, 2018 .

Association of an inflammatory gene signature with CD8 expression by immunohistochemistry (IHC) in multiple tumor types.

G. Dalgliesh, S. Ely, K. Zerba, 2019, Journal of Clinical Oncology.

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours

J. Desai, K. Gelmon, A. El-Khoueiry, 2018, Investigational New Drugs.

Evaluation and selection of a non-PCR based technology for improved gene expression profiling from clinical formalin-fixed, paraffin-embedded samples.

J. Cogswell, M. Ma-Edmonds, Aiqing He, 2016, Bioanalysis.

IRS 2 Copy Number Gain , KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1 R / IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines

Dharmesh M. Patel, Han Chang, F. Huang, 2015 .

Copy Number Gain , KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1 R / IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines

Dharmesh M. Patel, Han Chang, F. Huang, 2015 .